Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease
Authors
Keywords
-
Journal
IUBMB LIFE
Volume 64, Issue 10, Pages 846-852
Publisher
Wiley
Online
2012-07-21
DOI
10.1002/iub.1073
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson’s disease
- (2014) Alessandra Fanciulli et al. Pharmacological Reports
- Cellular models to investigate biochemical pathways in Parkinson’s disease
- (2012) Tiziana Alberio et al. FEBS Journal
- Proteomic analysis reveals that treatment with tocotrienols reverses the effect of H2O2 exposure on peroxiredoxin expression in human lymphocytes from young and old individuals
- (2012) Hasnizawati Mohamed Dahlan et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Parkinson's Disease: Genetics and Pathogenesis
- (2011) Joshua M. Shulman et al. Annual Review of Pathology-Mechanisms of Disease
- Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells
- (2011) Tiziana Alberio et al. BIOCHIMIE
- Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies
- (2011) Tiziana Alberio et al. JOURNAL OF BIOTECHNOLOGY
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Current approaches to the treatment of Parkinson’s disease
- (2011) Joseph Jankovic Neuropsychiatric Disease and Treatment
- Using ‘omics’ to define pathogenesis and biomarkers of Parkinson’s disease
- (2010) W Michael Caudle et al. Expert Review of Neurotherapeutics
- Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson’s disease pathogenesis
- (2010) Tiziana Alberio et al. FEBS Journal
- No increased chromosomal damage in l-DOPA-treated patients with Parkinson’s disease: a pilot study
- (2010) Rajaraman Gnana Oli et al. JOURNAL OF NEURAL TRANSMISSION
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- The immunoregulatory role of dopamine: An update
- (2009) Chandrani Sarkar et al. BRAIN BEHAVIOR AND IMMUNITY
- Levodopa in the treatment of Parkinson’s disease
- (2009) A. H. V. Schapira et al. EUROPEAN JOURNAL OF NEUROLOGY
- Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine
- (2009) Jerzy Ostrowski et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Role of dopamine in the physiology of T-cells and dendritic cells
- (2009) Rodrigo Pacheco et al. JOURNAL OF NEUROIMMUNOLOGY
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations
- (2008) A. Lupi et al. AMINO ACIDS
- Peripheral biomarkers of Parkinson’s disease as early reporters of central neurodegeneration
- (2008) Mauro Fasano et al. Biomarkers in Medicine
- Calcium Homeostasis Is Dysregulated in Parkinsonian Patients With l-DOPA-Induced Dyskinesias
- (2008) Fabio Blandini et al. CLINICAL NEUROPHARMACOLOGY
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins
- (2008) Jiri Petrak et al. PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started